Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca developing reversal agent for heart drug Brilinta
Yahoo/Reuters
Thursday, November 13, 2014 - 8:13am
tags:
AstraZeneca, Brilinta
U.S. gene study raises hope for Merck cholesterol drug Zetia
Yahoo/Reuters
Thursday, November 13, 2014 - 8:11am
tags:
Merck, Zetia
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wednesday, November 12, 2014 - 4:52pm
tags:
obesity, Contrave, Orexigen, Eisai
1 Biotech Beast Worth Tracking
Yahoo/Benzinga
Wednesday, November 12, 2014 - 4:37pm
tags:
Incyte, Merck, Novartis, Eli Lilly, Pfizer
Pharma Trade Group Head Causes a Stir With a Remark About Patents
WSJ Pharmalot
Wednesday, November 12, 2014 - 4:32pm
tags:
International Federation of Pharmaceutical Manufacturers Association, patents
Missing the old pharma swag? Take a trip down memory lane
Fierce Pharma Marketing
Wednesday, November 12, 2014 - 1:22pm
tags:
drug reps, pharma industry
Indian drugmakers see U.S. sales hit by delay in new approvals
Reuters
Wednesday, November 12, 2014 - 11:48am
tags:
India, FDA, drug approvals
Takeda's Millennium re-ups with Presage on cancer drug combo effort
Fierce Biotech
Wednesday, November 12, 2014 - 11:46am
tags:
Takeda, Millennium Pharmaceuticals, Presage Biosciences, cancer
Survey: Hospitals clamp down on medical device expenses
Mass Device
Wednesday, November 12, 2014 - 11:43am
tags:
devices
[video] What Makes Allergan an Attractive Target for Actavis?
Bloomberg
Wednesday, November 12, 2014 - 11:43am
tags:
Allergan, Actavis, M&A
Don’t expect a Dendreon sale; the troubled biotech will likely end up as a new entity with the current common shares cancelled
Barron's
Wednesday, November 12, 2014 - 11:02am
tags:
Dendreon, bankruptcy
Actavis Said in Talks to Acquire Allergan for Over $60 Billion
Bloomberg
Wednesday, November 12, 2014 - 10:50am
tags:
Actavis, Allergan, M&A
TEVA: Copaxone Patent Expiry Worries Are Overblown
Seeking Alpha
Wednesday, November 12, 2014 - 8:44am
tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, patents
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wednesday, November 12, 2014 - 8:41am
tags:
JNJ, Medivation, M&A, Xtandi, prostate cancer
Could Zoetis (ZTS) Be Ackman’s Next Pitch To Valeant Pharmaceuticals (VRX)?
Bidness Etc.
Wednesday, November 12, 2014 - 8:39am
tags:
Zoetis, Bill Ackman, M&A, Valeant Pharmaceuticals, animal health
Oxigene Faces Challenges for Ovarian Cancer Drug Even With Encouraging Data
TheStreet.com
Wednesday, November 12, 2014 - 8:38am
tags:
Oxigene, ovarian cancer, fosbretabulin, Avastin
Allergan amends shareholder meeting bylaws ahead of Dec. 18 meet
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:35am
tags:
Allergan, Valeant Pharmaceuticals, shareholders, M&A
Avanir's AVP-825 Approval Could be Delayed
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:35am
tags:
Avanir, AVP-825, migraines
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:33am
tags:
Bristol-Myers Squibb, hepatitis C, daclatasvir
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:32am
tags:
Amgen, psoriasis, JNJ, brodalumab, Stelara

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.